IP Library › Assignment 063189/0142
Patent Assignment
Reel/Frame 063189/0142

Partial Release of Intellectual Property Security Agreement

Recorded: 2023-03-29 Pages: 13
Assignor
Assignees
BAUDAX BIO, INC.
490 LAPP RD., MALVERN, PENNSYLVANIA, 19355
BAUDAX BIO N.A. LLC
490 LAPP RD., MALVERN, PENNSYLVANIA, 19355
BAUDAX BIO LIMITED
490 LAPP RD., MALVERN, PENNSYLVANIA, 19355
Covered Properties (10)
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Patent: 7,459,283 →
Application: 10/357,514 →
Publication: US 2003/0185869
Nanoparticulate meloxicam formulations
Patent: 8,512,727 →
Application: 10/784,900 →
Publication: US 2004/0229038
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Patent: 8,323,641 →
Application: 12/292,091 →
Publication: US 2009/0074875
Nanoparticulate Meloxicam Formulations
Application: 15/437,534 →
Publication: US 2017/0157061
Nanoparticulate Meloxicam Formulations
Application: 15/950,367 →
Publication: US 2018/0228809
Method of Treating Pain in Elderly Patients with Mild Renal Impairment
Application: 16/297,020 →
Publication: US 2019/0275053
Methods of Administering Intravenous Meloxicam in a Bolus Dose
Application: 16/297,095 →
Publication: US 2019/0275054
Nanoparticulate Meloxicam Formulations
Application: 16/550,239 →
Publication: US 2019/0381062
Methods of Administering Intravenous Meloxicam Pre-Operatively and in Combination with Other Drugs
Application: 17/287,489 →
Publication: US 2021/0386753
Methods of Treating Subjects Having Platelet Dysfunction with Iv Meloxicam
Application: 17/292,403 →
Publication: US 2022/0008430
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (Second Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Change of Name Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029104/0071 →
Assignment of Assignor's Interest Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029103/0465 →
Asset Transfer Agreement Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029108/0426 →
Change of Name Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029103/0695 →
Release by Secured Party (Second Lien) Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Property Transfer Agreement Aug 12, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033522/0048 →
Change of Name Mar 27, 2015
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 035279/0701 →
Business Transfer Agreement Apr 10, 2015
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035409/0831 →
Asset Transfer and License Agreement Apr 10, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: DV TECHNOLOGY LLC
Reel/Frame 035410/0001 →
Security Interest Apr 14, 2015
From: RECRO TECHNOLOGY LLC
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0288 →
Change of Name Apr 16, 2015
From: DV TECHNOLOGY LLC
To: RECRO TECHNOLOGY LLC
Reel/Frame 035446/0904 →
Release of Security Interest Apr 27, 2015
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED)
Reel/Frame 035505/0696 →
Merger Sep 23, 2016
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 039841/0365 →
Assignment of Assignor's Interest Oct 5, 2016
From: RECRO GAINESVILLE LLC
To: RECRO IRELAND LIMITED
Reel/Frame 039946/0789 →
Change of Name Jul 21, 2017
From: DV TECHNOLOGY LLC
To: RECRO TECHNOLOGY LLC
Reel/Frame 043296/0667 →
Assignment of Assignor's Interest Jul 21, 2017
From: RECRO GAINESVILLE LLC
To: RECRO PHARMA, INC.
Reel/Frame 043067/0111 →
Asset Transfer Agreement Jul 21, 2017
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 043288/0390 →
Merger Jul 21, 2017
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 043063/0644 →
Merger Jul 21, 2017
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 043060/0408 →
Change of Name Jul 21, 2017
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 043062/0208 →
Assignment of Assignor's Interest Jul 21, 2017
From: COOPER, EUGENE R.; RYDE, TUULA; PRUITT, JOHN; KLINE, LAURA
To: ELAN PHARMA INTERNATIONAL LTD.
Reel/Frame 043061/0526 →
Change of Name Jul 21, 2017
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 043301/0750 →
Property Transfer Agreement Jul 21, 2017
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 043332/0616 →